SEC Tracker
Get the app

Acadia Pharmaceuticals ACAD

Mark C. Schneyer (Officer) sold 3,321 ACAD at $20.88, worth $69K, under a 10b5-1 plan

Form
4
Filed
Importance
Routine
  1. Mark C. Schneyer sold 3,321 shares on Oct 30, 2026
  2. Shares sold at $20.88 per share
  3. Insider owned 71,322 shares after transaction

Written from the Form 4 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Acadia Pharmaceuticals files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Twist Bioscience TWST public float $2.3B, Mar 31, 2025, over 18 months old
  2. Xenon Pharmaceuticals XENE public float $2.4B, Jun 30, 2025
  3. Summit Therapeutics SMMT public float $2.5B, Jun 30, 2025
  4. Cytokinetics CYTK public float $2.5B, Jun 30, 2025
  5. TG Therapeutics TGTX public float $2.5B, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.